Succeed trial outcome is not going to be as big a mover as the panel voting to approve a drug that was considered third in a 3 horse race. That was a huge binary event! Aria doesn't even own Rida, MRK does. So yes, to your point it will not move the pps % wise as much as Contrave getting a thumbs up and the options will reflect that.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.